Effects of the immunosuppressive malononitrilamides on rheumatoid and systemic lupus erythematosus (SLE)-like diseases

International Journal of Immunotherapy

Volumn 13, Issue 1-2, 1997, Pages 1-7

  Schorlemmer, H U ^a,c   Bartlett, R R ^b  

^a Behringwerke AG   (Germany)

^b Werk Kalle Albert   (Germany)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; 2 CYANO N (4 CYANOPHENYL) 3 CYCLOPROPYL 3 OXOPROPIONAMIDE; AUTOANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE EROSION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; IMMUNOSUPPRESSIVE TREATMENT; INTRAGASTRIC DRUG ADMINISTRATION; LYMPHADENOPATHY; LYMPHOID HYPERPLASIA; MORTALITY; MOUSE; NONHUMAN; PROTEINURIA; RHEUMATIC DISEASE; SEROLOGY; SPLENOMEGALY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0031402564     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bartlett RR Brendel S, Zielinski T., Schorlemmer HU Leflunomide, an Immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthntis Transplant Proc , 28, 3074, 1996
2. Schorlemmer H.U , Seiler F.R , Bartlett R.R Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxaze derivative Transplant Proc., 25, 763, 1993
3. Morris R E , Huang X , Cao W, Zheng B , Shorthouse R A Leflunomide (HWA 486) and its analog suppress T- and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimai thickening after balloon catheter injury Transplant Proc , 27, 445, 1995.
4. Schorlemmer H.U., Schwab W., Ruuth E., Kurrle R Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides. Transplant Proc , 28, 3048, 1996.
5. Lin Y, Segers C , Waer M. Efficacy of the malononitnlamide X 920715 as compared with leflunomide in cardiac alto- and xeno-transplantation in rats. Transplant. Proc , 28, 3036, 1996.
6. Schorlemmer H U , Kurrie R. Control of mouse-to-rat skin xenograft rejection by malononitnlamides. Transplant. Proc , 28, 3037, 1996.
7. Kurrle R., Bartlett R., Ruuth E., Lauffer L., Schorlemmer H.U Malononitnlamides inhibit T- and B-cell responsiveness Transplant Proc., 28, 3053, 1996.
8. Kurrle R., Ruuth E , Bartlett R , Lauffer L , Schorlemmer H U Malononitnlamides inhibit T- and B-cell responsiveness in different species Transplant. Proc. 29, 1302 1997
9. Williamson R.A , Yea C M , Robson P.A., et al Dehydroorotate dehydrogenase is a high affinity binding protein for A 771726 and mediator of a range of biological effects of the immunomodulatory compound J Biol. Chem , 270, 22467, 1995
10. Schorlemmer H U , Bartlett R.R , Kurrle R. Analogues of leflunomide's primary metabolite the malononitnlamides, prevent the development of graft-versus-host disease. Transplant Proc. 29, 1298, 1997
11. Gleichmann E , van Elven E.H , van der Veen J PW. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B-cell cooperation Preferential formation of autoantibodies characteristic of SLE Eur J Immunol , 12, 152, 1982
12. Murphy E D , Roths J B Autoimmunity and lymphoproliferation Induction by mutant gene lpr and acceleration by a male-associated factor in strain B x SB mice in Rose N. et al. (eds.). :Genetic control of autoimmune disease Elsevier, New York 1978. p 207
13. Dubey C., Bellon B Druet P TH1 and TH2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals. Eur Cytokine Net , 2, 147, 1991